Chengpeng Gui

机构：First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Guangdong Pharmaceutical University, First Affiliated Hospital of Jinan University, Guangzhou Medical University · ORCID：0000-0003-1067-0377

发表论文 36 篇 · 总被引 472 次 · h-index 12

代表论文

• Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study (2023 · The Lancet Digital Health · 被引 47)
• EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1 (2023 · Advanced Science · 被引 46)
• PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma (2024 · Cancer Research · 被引 39)
• A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma (2024 · Nature Communications · 被引 20)
• N6-methyladenosine-mediated upregulation of MANF promotes ER stress resistance in renal cell carcinoma (2025 · Cell Death and Disease · 被引 7)
• Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinoma (2023 · Translational Oncology · 被引 7)